BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for CTI BioPharma Corp. (CTIC)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for CTI BioPharma Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-06-28
1:51 pm
Sale		 2023-06-26 13D CTI BioPharma Corp.
CTIC		 BIOTECHNOLOGY VALUE FUND L P 0
0.000%		 -28,463,021decrease
(Position Closed)		 Filing
2022-08-11
4:48 pm
Purchase		 2022-08-09 13D CTI BioPharma Corp.
CTIC		 BIOTECHNOLOGY VALUE FUND L P 28,463,021
19.990%		 11,339,998increase
(+66.23%)		 Filing
2021-03-15
07:55 am
Purchase		 2021-03-10 13D CTI BioPharma Corp.
CTIC		 BIOTECHNOLOGY VALUE FUND L P 17,123,023
19.990%		 4,369,333increase
(+34.26%)		 Filing